Erythrodermie avec presence de cellules monstrueuses dans le derme et le sang circulant. Bulletin de la Société Francaise de Dermatologie et de Syphiligraphie, pp.245-60, 1938. ,
S??zary Syndrome??? A Malignant Reticulemic Erythroderma, JAMA, vol.177, issue.7, pp.465-72, 1961. ,
DOI : 10.1001/jama.1961.03040330001001
The Ultrastructure of an Abnormal Cell in Sézary's Syndrome. Blood, pp.719-745, 1968. ,
SEZARY'S SYNDROME., British Journal of Dermatology, vol.9, issue.10, pp.335-378, 1959. ,
DOI : 10.1007/BF01949469
Cytogenetic, Cytophotometric, and Ultrastructural Study of Large Cerebriform Cells of the S??zary Syndrome and Description of a Small-Cell Variant
2
3, JNCI: Journal of the National Cancer Institute, vol.50, issue.5, pp.1145-62, 1973. ,
DOI : 10.1093/jnci/50.5.1145
Indications of the Thymus-Derived Nature of the Proliferating Cells in Six Patients with S??zary's Syndrome, New England Journal of Medicine, vol.289, issue.7, pp.341-345, 1973. ,
DOI : 10.1056/NEJM197308162890703
Cutaneous T-Cell Lymphomas: The Sézary Syndrome, Mycosis Fungoides, and Related Disorders, Ann Intern Med, vol.83, issue.4, pp.534-52, 1975. ,
Cutaneous T-Cell Lymphomas, Archives of Dermatology, vol.115, issue.9, pp.1103-1108, 1979. ,
DOI : 10.1001/archderm.1979.04010090053026
WHO- EORTC classification for cutaneous lymphomas. Blood, pp.3768-85, 2005. ,
Incidence of cutaneous T-cell lymphoma in the United States, Arch Dermatol, vol.143, issue.7, pp.854-863, 1973. ,
The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. ASH Educ Program Book, pp.523-554, 2009. ,
Peripheral blood Sézary cells and the diagnosis of Sézary syndrome], Ann Biol Clin, vol.66, issue.4, pp.447-53, 2008. ,
Mycosis fungoides: Review of Epidemiological Observations, Dermatology, vol.201, issue.1, pp.21-29, 2000. ,
DOI : 10.1159/000018423
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma, Discov Med, vol.16, issue.87, pp.71-79, 2013. ,
Cutaneous T Cell Lymphoma, Annals of the New York Academy of Sciences, vol.91, issue.4, pp.1-11, 2001. ,
DOI : 10.1111/j.1749-6632.2001.tb03705.x
The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells. Blood, pp.2929-2968, 2002. ,
Mycosis fungoides: is it a Borrelia burgdorferi-associated disease? Br J Cancer, Feb, vol.2194, issue.6, pp.879-83, 2006. ,
Association between Sézary T Cellactivating Factor, Chlamydia pneumoniae, and Cutaneous T Cell Lymphoma ,
Sézary T- Cell Activating Factor Is aChlamydia pneumoniae-Associated Protein, Clin Diagn Lab Immunol, vol.6, issue.6, pp.895-905, 1999. ,
Association of Erythrodermic Cutaneous T-Cell Lymphoma, Superantigen-Positive Staphylococcus aureus, and Oligoclonal T-Cell Receptor V? Gene Expansion, Blood, vol.89, issue.1, pp.32-40, 1997. ,
Cytomegalovirus: its potential role in the development of cutaneous T-cell lymphoma, Experimental Dermatology, vol.17, issue.6, pp.574-580, 2009. ,
DOI : 10.1111/j.1600-0625.2008.00817.x
A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2, Blood, vol.116, issue.10, pp.1637-1684, 2009. ,
DOI : 10.1182/blood-2009-12-256586
Les lymphomes T épidermotropes comme modèles de progression tumorale. médecine/sciences, Feb, vol.22, issue.2, pp.192-198, 2006. ,
BCL2 and JUNB abnormalities in primary cutaneous lymphomas, British Journal of Dermatology, vol.22, issue.3, pp.546-56, 2004. ,
DOI : 10.1046/j.1523-1747.2003.12496.x
Aberrant expression of T-plastin in Sezary cells, Cancer Res, vol.63, issue.21, pp.7122-7129, 2003. ,
Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study, Blood, vol.102, issue.3, 2003. ,
DOI : 10.1182/blood-2002-11-3574
Immunopathogenesis of cutaneous T-cell lymphomas, Hematology/Oncology Clinics of North America, vol.17, issue.6, pp.1313-1320, 2003. ,
DOI : 10.1016/S0889-8588(03)00116-3
Syndrome de sézary. Rev Fr Lab, pp.51-57, 2004. ,
Dysregulated Synthesis of Intracellular Type 1 and Type 2 Cytokines by T Cells of Patients with Cutaneous T-Cell Lymphoma, Clin Diagn Lab Immunol, 1999. ,
Sezary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines, Blood, vol.100, issue.9, pp.3287-94, 2002. ,
DOI : 10.1182/blood-2002-01-0231
Circulating Natural Killer Lymphocytes Are Potential Cytotoxic Effectors Against Autologous Malignant Cells in Sezary Syndrome Patients, Journal of Investigative Dermatology, vol.125, issue.6, pp.1273-1281, 2005. ,
DOI : 10.1111/j.0022-202X.2005.23914.x
Cutaneous T Cell Lymphoma Reactive CD4+ Cytotoxic T Lymphocyte Clones Display a Th1 Cytokine Profile and Use a Fas-Independent Pathway for Specific Tumor Cell Lysis, Journal of Investigative Dermatology, vol.115, issue.1, pp.74-80, 2000. ,
DOI : 10.1046/j.1523-1747.2000.00995.x
Septicemic complications of the cutaneous T-cell lymphomas, The American Journal of Medicine, vol.71, issue.2, pp.210-216, 1981. ,
DOI : 10.1016/0002-9343(81)90107-8
Infections Complicating Mycosis Fungoides and S??zary Syndrome, JAMA: The Journal of the American Medical Association, vol.267, issue.10, pp.1354-1362, 1992. ,
DOI : 10.1001/jama.1992.03480100060031
Rôle du TGF? dans le cancer chez l'humain: de la suppression tumorale vers le développement des métastases, Med Sci Ameriques, pp.1-18, 2012. ,
CD4+CD7??? leukemic T cells from patients with S??zary syndrome are protected from galectin-1-triggered T cell death, Leukemia, vol.16, issue.5, pp.840-845, 2002. ,
DOI : 10.1038/sj.leu.2402438
Mycosis fungoides and Sezary syndrome, Blood, vol.88, issue.7, pp.2385-409, 1996. ,
Aberrant Cytokine Production By Sezary Syndrome Patients: Cytokine Secretion Pattern Resembles Murine Th2 Cells, Journal of Investigative Dermatology, vol.99, issue.1, pp.90-94, 1992. ,
DOI : 10.1111/1523-1747.ep12611877
Immune Function Abnormalities in Peripheral Blood Mononuclear Cell Cytokine Expression Differentiates Stages of Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Clinical Cancer Research, vol.14, issue.3, pp.646-53, 2008. ,
DOI : 10.1158/1078-0432.CCR-07-0610
Immunopathogenesis and therapy of cutaneous T cell lymphoma, Journal of Clinical Investigation, vol.115, issue.4, pp.798-812, 2005. ,
DOI : 10.1172/JCI200524826
Interleukin-7 receptor expression in cutaneous T-cell lymphomas, British Journal of Dermatology, vol.71, issue.4, pp.572-577, 1996. ,
DOI : 10.1038/332083a0
Interleukin-7 is a growth factor for S??zary lymphoma cells., Journal of Clinical Investigation, vol.90, issue.3, pp.1054-60, 1992. ,
DOI : 10.1172/JCI115920
Functional characterization of an IL-7?dependent CD4+CD8??+ Th3-type malignant cell line derived from a patient with a cutaneous T-cell lymphoma, Blood, vol.96, issue.3, pp.1056-63, 2000. ,
Expression et r??les de la T-plastine dans les lymphomes T cutan??s, Annales de Dermatologie et de V??n??r??ologie, vol.139, issue.12, pp.72-75, 2012. ,
DOI : 10.1016/j.annder.2012.10.053
Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors, Blood, vol.116, issue.5, pp.767-71, 2010. ,
DOI : 10.1182/blood-2009-11-251926
Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome, Blood, vol.113, issue.1, pp.127-163, 2009. ,
DOI : 10.1182/blood-2008-04-153031
Update on erythrodermic cutaneous T-cell lymphoma: Report of the international society for cutaneous lymphomas, Journal of the American Academy of Dermatology, vol.46, issue.1, pp.95-106, 2002. ,
DOI : 10.1067/mjd.2002.118538
S??zary syndrome: Diagnosis, prognosis, and critical review of treatment options, Journal of the American Academy of Dermatology, vol.22, issue.3, pp.381-401, 1990. ,
DOI : 10.1016/0190-9622(90)70054-L
Actualit??s sur le syndrome de S??zary, Annales de dermatologie et de vénéréologie, pp.31-40, 2014. ,
DOI : 10.1016/j.annder.2011.09.188
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC), Blood, vol.110, issue.6, pp.1713-1735, 2007. ,
DOI : 10.1182/blood-2007-03-055749
Mycosis fungoides and the S??zary syndrome: Pathology, staging, and treatment, Current Problems in Cancer, vol.14, issue.6, pp.297-361, 1990. ,
DOI : 10.1016/0147-0272(90)90018-L
Treatment of mycosis fungoides with photochemotherapy (PUVA): Long-term follow-up, Journal of the American Academy of Dermatology, vol.33, issue.2, pp.234-276, 1995. ,
DOI : 10.1016/0190-9622(95)90241-4
Immunologic Differentiation of the S??zary Syndrome Due to Cutaneous T-Cell Lymphoma and Chronic Actinic Dermatitis, Journal of Investigative Dermatology, vol.86, issue.2, 1986. ,
DOI : 10.1111/1523-1747.ep12284160
HYdantoin-induced cutaneous pseudolymphoma with clinical, pathologic, and immunologic aspects of sézary syndrome, Arch Dermatol, vol.128, issue.10, pp.1371-1375, 1992. ,
CD158K/KIR3DL2 Transcript Detection in Lesional Skin of Patients with Erythroderma Is a Tool for the Diagnosis of S??zary Syndrome, Journal of Investigative Dermatology, vol.128, issue.2, pp.465-72, 2008. ,
DOI : 10.1038/sj.jid.5701013
A histologic study of lymph nodes from patients with the sézary syndrome. Cancer, Jun, vol.1557, issue.12, pp.2375-80, 1986. ,
Erythroderma with atypical lymphocytes (S??zary syndrome), The American Journal of Medicine, vol.55, issue.2, pp.192-200, 1973. ,
DOI : 10.1016/0002-9343(73)90168-X
Clinical studies of T-cell erythroderma in the Sezary syndrome, Mayo Clin Proc, vol.49, issue.8, pp.519-544, 1974. ,
Absolute Number of Circulating S??zary Cells, Archives of Dermatology, vol.117, issue.7, pp.382-382, 1981. ,
DOI : 10.1001/archderm.1981.01650070006008
Evaluation of circulating malignant cells provides prognostic information in cutaneous T cell lymphoma, Blood, vol.69, issue.3, pp.841-850, 1987. ,
Diagnostic Criteria in S??zary's Syndrome: A Multiparameter Study of Peripheral Blood Lymphocytes in 32 Patients with Erythroderma, Journal of Investigative Dermatology, vol.81, issue.5, 1983. ,
DOI : 10.1111/1523-1747.ep12521991
EORTC Classification for Primary Cutaneous Lymphomas: A Proposal From the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer, Blood, vol.90, issue.1, pp.354-71, 1997. ,
The relevance of the CD4+???CD26- subset in the identification of circulating S??zary cells, British Journal of Dermatology, vol.88, issue.1, pp.125-160, 2001. ,
DOI : 10.1046/j.1365-2133.2001.04014.x
Demonstration of Frequent Occurrence of Clonal T Cells in the Peripheral Blood of Patients With Primary Cutaneous T-Cell Lymphoma. Blood, pp.1636-1678, 1997. ,
Prise en charge des lymphomes T cutan??s??: recommandations du Groupe fran??ais d?????tude des lymphomes cutan??s, Annales de Dermatologie et de V??n??r??ologie, vol.137, issue.10, 2010. ,
DOI : 10.1016/j.annder.2010.06.021
CD158k/KIR3DL2 Is a New Phenotypic Marker of Sezary Cells: Relevance for the Diagnosis and Follow-Up of Sezary Syndrome, Journal of Investigative Dermatology, vol.122, issue.3, pp.820-823, 2004. ,
DOI : 10.1111/j.0022-202X.2004.22326.x
Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma, International Journal of Dermatology, vol.9, issue.3, pp.243-52, 2009. ,
DOI : 10.1111/j.1365-4632.2009.03771.x
Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma, Blood, vol.97, issue.3, pp.624-654, 2001. ,
DOI : 10.1182/blood.V97.3.624
Survival Outcomes and Prognostic Factors in Mycosis Fungoides/S??zary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal, Journal of Clinical Oncology, vol.28, issue.31, pp.4730-4739, 2010. ,
DOI : 10.1200/JCO.2009.27.7665
Prognostic Factors in Erythrodermic Mycosis Fungoides and the S??zary Syndrome, Archives of Dermatology, vol.131, issue.9, pp.1003-1011, 1995. ,
DOI : 10.1001/archderm.1995.01690210033005
Prognostic Value of Blood Eosinophilia in Primary Cutaneous T-Cell Lymphomas, Archives of Dermatology, vol.140, issue.9, pp.1057-61, 2004. ,
DOI : 10.1001/archderm.140.9.1057
Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features, Annals of Oncology, vol.9, issue.8, pp.857-63, 1998. ,
DOI : 10.1023/A:1008397323199
TCR??-Chain Gene Rearrangement by GeneScan: Incidence and Significance of Clonal Heterogeneity in S??zary Syndrome, Journal of Investigative Dermatology, vol.130, issue.9, pp.2312-2321, 2010. ,
DOI : 10.1038/jid.2010.97
Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas. Cancer Treat Rep, pp.725-733, 1979. ,
Erythroderma: review of 82 cases, South Med J, vol.79, issue.10, pp.1210-1215, 1986. ,
Subacute cutaneous lupus erythematosus presenting as erythroderma, Journal of the American Academy of Dermatology, vol.19, issue.2, pp.388-92, 1988. ,
DOI : 10.1016/S0190-9622(88)70184-X
Circulating Sezary cells in hospitalized dermatology patients, British Journal of Dermatology, vol.49, issue.2, pp.171-179, 1978. ,
DOI : 10.1001/archderm.111.1.29
Circulating cerebriform lymphoid cells (sezary-type cells) in a b-cell malignant lymphoma. Cancer, pp.1587-93, 1988. ,
Actinic reticuloid, Journal of the American Academy of Dermatology, vol.21, issue.2, pp.205-219, 1989. ,
DOI : 10.1016/S0190-9622(89)70162-6
Jessner's lymphocytic infiltration of the skin. A clinical study of 100 patients, Archives of Dermatology, vol.125, issue.11, pp.1525-1555, 1989. ,
DOI : 10.1001/archderm.125.11.1525
Genotyping of Cutaneous T-Cell Lymphomas and Pseudolymphomas, Current Problems in Dermatology [Internet]. S. Karger AG, pp.114-137, 1989. ,
DOI : 10.1159/000418081
Cutaneous pseudo-T-cell lymphomas, Semin Diagn Pathol, vol.8, issue.2, pp.102-110, 1991. ,
Cutaneous pseudo-T-cell lymphomas. A clinicopathologic study of 20 patients. Cancer, Feb, vol.169, issue.3, pp.717-741, 1992. ,
The nosology of parapsoriasis, Journal of the American Academy of Dermatology, vol.5, issue.4, pp.373-95, 1981. ,
DOI : 10.1016/S0190-9622(81)70100-2
Poikilodermatous Mycosis Fungoides and Atrophic Large-Plaque Parapsoriasis Exhibit Similar Abnormalities of T-Cell Antigen Expression, Archives of Dermatology, vol.124, issue.3, pp.366-72, 1988. ,
DOI : 10.1001/archderm.1988.01670030032018
Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign--histologically malignant, Archives of Dermatology, vol.97, issue.1, pp.23-30, 1968. ,
DOI : 10.1001/archderm.97.1.23
The clinical and histological spectrum of lymphomatoid papulosis, British Journal of Dermatology, vol.1, issue.2, pp.131-175, 1982. ,
DOI : 10.1007/BF00709158
Lymphomatoid Papulosis: A T-Cell Dyscrasia with a Propensity To Transform into Malignant Lymphoma, Annals of Internal Medicine, vol.122, issue.3, pp.210-217, 1995. ,
DOI : 10.7326/0003-4819-122-3-199502010-00009
Alopecia Mucinosa, A.M.A. Archives of Dermatology, vol.76, issue.4, pp.419-443, 1957. ,
DOI : 10.1001/archderm.1957.01550220027005
Alopecia mucinosa and lymphoma. Report of two cases and review of literature, Archives of Dermatology, vol.92, issue.2, pp.137-178, 1965. ,
DOI : 10.1001/archderm.92.2.137
Alopecia Mucinosa of the Face Associated With Mycosis Fungoides, Archives of Dermatology, vol.114, issue.5, pp.791-793, 1978. ,
DOI : 10.1001/archderm.1978.01640170087021
Pagetoid Reticulosis. (Woringer-Kolopp Disease), Journal of Cutaneous Pathology, vol.10, issue.2, pp.113-136, 1979. ,
DOI : 10.1001/archderm.114.2.262
Disseminated pagetoid reticulosis associated with mycosis fungoides: Immunomorphologic study, Journal of the American Academy of Dermatology, vol.14, issue.5, pp.898-901, 1986. ,
DOI : 10.1016/S0190-9622(86)70107-2
Localized and disseminated pagetoid reticulosis. Diagnostic immunophenotypical findings, Archives of Dermatology, vol.125, issue.3, pp.402-408, 1989. ,
DOI : 10.1001/archderm.125.3.402
Granulomatous slack skin, J Invest Dermatol, vol.89, issue.2, pp.183-189, 1987. ,
DOI : 10.1007/978-3-642-57624-9_13
Primary cutaneous CD30-positive large cell lymphoma: Definition of a new type of cutaneous lymphoma with a favorable prognosis.A European multicenter study of 47 patients, Cancer, vol.19, issue.6, pp.2097-104, 1993. ,
DOI : 10.1002/1097-0142(19930315)71:6<2097::AID-CNCR2820710626>3.0.CO;2-7
Adult T-cell leukemia, Blood Reviews, vol.2, issue.4, pp.481-92, 1977. ,
DOI : 10.1016/0268-960X(88)90012-4
Review of the Treatment of Mycosis Fungoides and Sézary Syndrome: A Stage-Based Approach, J Natl Compr Canc Netw, vol.6, issue.4, pp.436-478, 2008. ,
New and established treatment options for mycosis fungoides and S??zary syndrome - an update, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, vol.120, issue.11, pp.561-570 ,
DOI : 10.1111/ddg.12376
Regulation of Leukocyte-Endothelial Interactions by Glucocorticoids, Annals of the New York Academy of Sciences, vol.86, issue.1, pp.108-126, 2002. ,
DOI : 10.1111/j.1749-6632.2002.tb04208.x
Nuclear Factor-?B ? A Pivotal Transcription Factor in Chronic Inflammatory Diseases, N Engl J Med Apr, vol.10336, issue.15, pp.1066-71, 1997. ,
Secondary cancers, comorbidities and mortality associated with nitrogen mustard therapy in patients with mycosis fungoides: a 30-year population-based cohort study, British Journal of Dermatology, vol.74, issue.3, pp.699-704, 2014. ,
DOI : 10.1111/bjd.12620
Topical Nitrogen Mustard in the Management of Mycosis Fungoides, Archives of Dermatology, vol.139, issue.2, pp.165-73, 2003. ,
DOI : 10.1001/archderm.139.2.165
Bexarotene therapy for mycosis fungoides and S??zary syndrome, British Journal of Dermatology, vol.104, issue.6, pp.1299-307, 2009. ,
DOI : 10.1111/j.1365-2133.2009.09037.x
Biological Effects of Bexarotene in Cutaneous T-Cell Lymphoma, Archives of Dermatology, vol.141, issue.3, pp.315-335, 2005. ,
DOI : 10.1001/archderm.141.3.315
Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: Reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine, American Journal of Hematology, vol.10, issue.9, pp.792-799, 2007. ,
DOI : 10.1002/ajh.20952
New and Experimental Skin-Directed Therapies for Cutaneous Lymphomas, Skin Pharmacology and Physiology, vol.22, issue.6, pp.322-356, 2009. ,
DOI : 10.1159/000241302
Topical carmustine (BCNU) in the treatment of mycosis fungoides, Dermatologic Therapy, vol.42, issue.4, pp.299-302, 2003. ,
DOI : 10.1001/archderm.106.2.177
Mécanismes d'action de l'imiquimod et implication dans le traitement des affections cutanées virales humaines et animales. Prat Médicale Chir Anim Cie, pp.105-117, 2013. ,
Imiquimod, Archives of Dermatology, vol.139, issue.10, pp.1347-50, 2003. ,
DOI : 10.1001/archderm.139.10.1347
Extracorporeal photopheresis for the treatment of S??zary syndrome using a novel treatment protocol, Journal of the American Academy of Dermatology, vol.59, issue.4, pp.589-95, 2008. ,
DOI : 10.1016/j.jaad.2008.05.038
Inhibition of Histone Deacetylation: A Strategy for Tumor Radiosensitization, Journal of Clinical Oncology, vol.25, issue.26, pp.4051-4057, 2007. ,
DOI : 10.1200/JCO.2007.11.6202
Total skin electron irradiation therapy in mycosis fungoides using high-dose rate mode: A preliminary experience, International Journal of Dermatology, vol.15, issue.0, pp.828-858, 2005. ,
DOI : 10.1016/S0360-3016(97)00585-3
Total skin electron radiation in the management of mycosis fungoides: Consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group, Journal of the American Academy of Dermatology, vol.47, issue.3, pp.364-70, 2002. ,
DOI : 10.1067/mjd.2002.123482
Interferon in the treatment of cutaneous T-cell lymphoma, Hematol Oncol Clin North Am, vol.9, issue.5, pp.1089-107, 1995. ,
Alemtuzumab for relapsed and refractory erythrodermic cutaneous T-cell lymphoma: a single institution experience from the Robert H. Lurie Comprehensive Cancer Center, Leukemia & Lymphoma, vol.90, issue.12, pp.1969-76, 2009. ,
DOI : 10.1046/j.1523-1747.2003.12402.x
Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma, Blood, vol.109, issue.11, pp.4655-62, 2007. ,
DOI : 10.1182/blood-2006-12-062877
Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma, Journal of Clinical Oncology, vol.32, issue.11, pp.1157-63, 2014. ,
DOI : 10.1200/JCO.2013.52.0924
Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma, Journal of Clinical Oncology, vol.25, issue.21, pp.3109-3124, 2007. ,
DOI : 10.1200/JCO.2006.10.2434
Low-dose methotrexate to treat mycosis fungoides: a retrospective study in 69 patients, Journal of the American Academy of Dermatology, vol.49, issue.5, pp.873-881, 2003. ,
DOI : 10.1016/S0190-9622(03)01591-3
Gemcitabine: a cytidine analogue active against solid tumors. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm, pp.162-70, 1997. ,
Gemcitabine treatment in cutaneous T-cell lymphoma: a multicentre study of 23 cases, British Journal of Dermatology, vol.31, issue.3, pp.660-663, 2009. ,
DOI : 10.1111/j.1365-2133.2009.09230.x
Treatment of advanced cutaneous T-cell lymphomas with non-pegylated liposomal doxorubicin - Consensus of the lymphoma group of the Working Group Dermatologic Oncology, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, vol.24, issue.5, 2013. ,
DOI : 10.1111/ddg.12012
Durable Remission of Sézary Syndrome after Unrelated Bone Marrow Transplantation by Reduced-Intensity Conditioning, Acta Haematologica, vol.120, issue.1, pp.14-22, 2008. ,
DOI : 10.1159/000151510
Allogeneic Hematopoietic Cell Transplantation for Patients With Mycosis Fungoides and S??zary Syndrome: A Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation, Journal of Clinical Oncology, vol.28, issue.29, pp.4492-4501, 2010. ,
DOI : 10.1200/JCO.2010.29.3241
La cytométrie en flux: intérêt et applications en hématologie. Rev Fr Lab, pp.29-35, 1995. ,
Le lymphome cutané de type Sézary et Bouvrain, Progrès physiopathologiques et perspectives thérapeutiques, pp.927-965, 1998. ,
Surface antigens on malignant Sezary and T-CLL cells correspond to those of mature T cells, Blood, vol.57, issue.3, pp.526-556, 1981. ,
Detection of circulating T cells with CD4+CD7??? immunophenotype in patients with benign and malignant lymphoproliferative dermatoses, Journal of the American Academy of Dermatology, vol.35, issue.3, pp.404-414, 1996. ,
DOI : 10.1016/S0190-9622(96)90605-2
Differential Diagnosis of T-Cell Lymphoproliferative Disorders by Flow Cytometry Multicolor Immunophenotyping. Correlation with Morphology, Methods Cell Biol, vol.75, pp.595-621, 2004. ,
DOI : 10.1016/S0091-679X(04)75025-6
Differential expression of T cell antigens in normal peripheral blood lymphocytes: a quantitative analysis by flow cytometry., Journal of Clinical Pathology, vol.49, issue.7, pp.539-583, 1996. ,
DOI : 10.1136/jcp.49.7.539
CD4+/CD7??? T Cell Frequency and Polymerase Chain Reaction-Based Clonality Assay Correlate with Stage in Cutaneous T Cell Lymphomas, Journal of Investigative Dermatology, vol.114, issue.1, pp.107-118, 2000. ,
DOI : 10.1046/j.1523-1747.2000.00818.x
CD7-T cells represent a subset of normal human blood lymphocytes, J Immunol, vol.150, issue.5, pp.2081-2090, 1993. ,
T Cell Signal Transduction and the Role of CD7 in Costimulation, Immunologic Research, vol.24, issue.1, pp.31-52, 2001. ,
DOI : 10.1385/IR:24:1:31
Simplified Flow Cytometric Assessment in Mycosis Fungoides and Sezary Syndrome, American Journal of Clinical Pathology, vol.136, issue.6, 2011. ,
DOI : 10.1309/AJCP09OTJOYAVZZK
Progressive increase of CD7- T cells in human blood lymphocytes with ageing, Clinical & Experimental Immunology, vol.149, issue.1, pp.163-171, 1994. ,
DOI : 10.1111/j.1365-2249.1994.tb06624.x
CD7-Negative Helper T Cells Accumulate in Inflammatory Skin Lesions, Journal of Investigative Dermatology, vol.102, issue.3, pp.328-360, 1994. ,
DOI : 10.1111/1523-1747.ep12371791
Defective expression of T cell-associated glycoprotein in severe combined immunodeficiency., Journal of Clinical Investigation, vol.77, issue.3, pp.940-946, 1986. ,
DOI : 10.1172/JCI112393
Immunophenotypic identification of Sezary cells in peripheral blood, Am J Clin Pathol, vol.106, issue.6, pp.739-787, 1996. ,
Lymphocytes subsets in normal individuals: analysis by four color immunofluorescence and flow cytometry on whole blood, Tissue Antigens, vol.79, issue.4, pp.312-320, 1996. ,
DOI : 10.1111/j.1399-0039.1996.tb02650.x
Skin homing of Sezary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV, Blood, vol.107, issue.3, pp.1108-1123, 2006. ,
DOI : 10.1182/blood-2005-04-1492
Expression of CD26 (Dipeptidyl Peptidase IV) on Resting and Activated Human T-Lymphocytes, Scandinavian Journal of Immunology, vol.31, issue.97 ,
DOI : 10.1016/0008-8749(85)90400-9
The Pathogenesis of Mycosis Fungoides, New England Journal of Medicine, vol.350, issue.19, pp.1978-88, 2004. ,
DOI : 10.1056/NEJMra032810
Kinetic Investigation of Chemokine Truncation by CD26/Dipeptidyl Peptidase IV Reveals a Striking Selectivity within the Chemokine Family, Journal of Biological Chemistry, vol.276, issue.32, 2001. ,
DOI : 10.1074/jbc.M103106200
Role of CD26/dipeptidyl peptidase IV in human T cell activation and function, Frontiers in Bioscience, vol.13, issue.13, pp.2299-310, 2008. ,
DOI : 10.2741/2844
The role of CD26/dipeptidyl peptidase IV in cancer, Frontiers in Bioscience, vol.13, issue.13, pp.1634-1679, 2008. ,
DOI : 10.2741/2787
1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation, J Immunol, vol.147, issue.9, pp.2825-2857, 1991. ,
CD26/dipeptidyl peptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkin's lymphomas, Human Pathology, vol.25, issue.12, 1994. ,
DOI : 10.1016/0046-8177(94)90098-1
Absence of CD26 Expression Is a Useful Marker for Diagnosis of T-Cell Lymphoma in Peripheral Blood, American Journal of Clinical Pathology, vol.115, issue.6, pp.885-92, 2001. ,
DOI : 10.1309/U1Y6-J4AG-5M4M-7AYV
The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer, Journal of Experimental Medicine, vol.184, issue.2, pp.505-523, 1996. ,
DOI : 10.1084/jem.184.2.505
Significance of circulating T-cell clones in Sezary syndrome, Blood, vol.107, issue.10, pp.4030-4038, 2006. ,
DOI : 10.1182/blood-2005-10-4239
Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes, Immunological Reviews, vol.154, issue.1, pp.105-122, 1997. ,
DOI : 10.1006/clin.1994.1029
Different NK Cell Surface Phenotypes Defined by the DX9 Antibody Are Due to KIR3DL1 Gene Polymorphism, The Journal of Immunology, vol.166, issue.5, pp.2992-3001, 2001. ,
DOI : 10.4049/jimmunol.166.5.2992
Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses, Immunology Today, vol.19, issue.4, pp.153-160, 1998. ,
DOI : 10.1016/S0167-5699(97)01236-X
Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future, Nature Reviews Immunology, vol.170, issue.3, pp.190-198, 2004. ,
DOI : 10.1038/nri1306
CD158k/KIR3DL2 is a useful marker for identifying neoplastic T-cells in S??zary syndrome by flow cytometry, Cytometry Part B: Clinical Cytometry, vol.4, issue.3, pp.156-62, 2008. ,
DOI : 10.1002/cyto.b.20395
Absolute CD3+ CD158k+ lymphocyte count is reliable and more sensitive than 98 ,
S??zary syndrome lymphocytes, The Journal of Pathology, vol.36, issue.1, pp.77-83, 2003. ,
DOI : 10.1002/path.1251
On the diagnosis of erythrodermic cutaneous T-cell lymphoma, Journal of Cutaneous Pathology, vol.132, issue.2, pp.27-42, 2006. ,
DOI : 10.1038/sj.leu.2400710
Prognostic Significance of a Polymerase Chain Reaction?Detectable Dominant T-Lymphocyte Clone in Cutaneous Lesions of Patients With Mycosis Fungoides, Blood, vol.92, issue.9, pp.3376-80, 1998. ,
Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma, Blood, vol.96, issue.9, pp.2987-92, 2000. ,
Evidence that an Identical T Cell Clone in Skin and Peripheral Blood Lymphocytes is an Independent Prognostic Factor in Primary Cutaneous T Cell Lymphomas, Journal of Investigative Dermatology, vol.117, issue.4, pp.920-926, 2001. ,
DOI : 10.1046/j.0022-202x.2001.01476.x
The diagnosis of S??zary syndrome on peripheral blood by flow cytometry requires the use of multiple markers, British Journal of Dermatology, vol.22, issue.Suppl. 1, pp.871-80, 2008. ,
DOI : 10.1111/j.1365-2133.2008.08739.x
Flow cytometric detection of peripheral blood involvement by mycosis fungoides and Sézary syndrome using T-cell receptor Vbeta chain antibodies and its application in blood staging, Mod Pathol Off J U S Can Acad Pathol Inc, 2010. ,
Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndrome, Blood, vol.89, issue.9, pp.3371-3378, 1997. ,
WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects, Journal of Cutaneous Pathology, vol.35, issue.10, pp.647-74, 2005. ,
DOI : 10.1002/cncr.10489.abs
Molecular cytogenetic characterization of S??zary syndrome, Genes, Chromosomes and Cancer, vol.20, issue.3, pp.250-60, 2003. ,
DOI : 10.1002/gcc.10152
Novel and Highly Recurrent Chromosomal Alterations in Sezary Syndrome, Cancer Research, vol.68, issue.8, pp.2689-98, 2008. ,
DOI : 10.1158/0008-5472.CAN-07-6398
Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells, Leukemia, vol.13, issue.5, pp.735-743, 1999. ,
DOI : 10.1038/sj.leu.2401415
STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes, Blood, vol.108, issue.3, pp.1058-64, 2006. ,
DOI : 10.1182/blood-2005-08-007377
MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential, Blood, vol.116, issue.7, pp.1105-1118, 2010. ,
DOI : 10.1182/blood-2009-12-256719
The spectrum of cutaneous T-cell lymphomas: new insights into biology and therapy, Current Opinion in Hematology, vol.12, issue.4, 2005. ,
DOI : 10.1097/01.moh.0000166498.64515.03
Histopathologic Staging at Initial Diagnosis of Mycosis Fungoides and the S??zary Syndrome, Annals of Internal Medicine, vol.109, issue.5, pp.372-82, 1988. ,
DOI : 10.7326/0003-4819-109-5-372
Morphological aspects of T cell subpopulations in human blood: characterization of the cerebriform mononuclear cells in healthy individuals, Clin Exp Immunol, vol.43, issue.3, pp.506-522, 1981. ,
Analysis, and TCR-PCR in Qualitative and Quantitative Assessment of Peripheral Blood Involvement by S??zary Syndrome, American Journal of Clinical Pathology, vol.125, issue.3, pp.364-74, 2006. ,
DOI : 10.1309/25E9Y7RRAY84HTAT
Alarms and Parameters Generated by Hematology Analyzer: New Tools to Predict and Quantify Circulating Sezary Cells, Journal of Clinical Laboratory Analysis, vol.106, issue.2, 2014. ,
DOI : 10.1002/jcla.21744
Mechanisms of action of extracorporeal photochemotherapy, Transfusion and Apheresis Science, vol.29, issue.1, pp.61-70, 2003. ,
DOI : 10.1016/S1473-0502(03)00103-4
Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy, New England Journal of Medicine, vol.316, issue.6, pp.297-303, 1987. ,
DOI : 10.1056/NEJM198702053160603
Guidelines on the use of extracorporeal photopheresis, Journal of the European Academy of Dermatology and Venereology, vol.36, issue.4, pp.1-37, 2014. ,
DOI : 10.1111/jdv.12311
La cytométrie en flux: ostface de, Gérard Martet,... Editions Tec & Doc, 2006. ,
Analyse d'image en cytologie hématologique: automate CellaVision DM96 TM, Annales de Biologie Clinique, pp.419-443, 2009. ,
Transimmunization and the evolution of extracorporeal photochemotherapy, Transfusion and Apheresis Science, vol.26, issue.3, 2002. ,
DOI : 10.1016/S1473-0502(02)00011-3
IPH4102, a Humanized KIR3DL2 Antibody with Potent Activity against Cutaneous T-cell Lymphoma, Cancer Research, vol.74, issue.21, pp.6060-70, 2014. ,
DOI : 10.1158/0008-5472.CAN-14-1456
A novel targeted immunotherapy for CTCL is on its way: Anti-KIR3DL2 mAb IPH4102 is potent and safe in non-clinical studies, OncoImmunology, vol.4, issue.9, p.1022306, 2015. ,
DOI : 10.1158/1078-0432.CCR-12-3488
MicroRNA-21 Expression in CD4+ T Cells Is Regulated by STAT3 and Is Pathologically Involved in S??zary Syndrome, Journal of Investigative Dermatology, vol.131, issue.3, 2011. ,
DOI : 10.1038/jid.2010.349